REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca Bulgaria EOOD (Bulgaria)

Main Activities: Advertising Agencies
Full name: Astrazeneca Bulgaria EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

AstraZeneca Bulgaria was established in 1999 after the merge between the pharmaceutical companies Astra AB and Zeneca Group PLS.
In 2000 the company opened a department for clinical tests and trials in Bulgaria. AstraZeneca produces medicines and pharmaceuticals in the field of cardiology, gastroenterology, oncology, pulmonology, anesthesiology, central nervous system.
AstraZeneca Bulgaria operates as a marketer of the pharmaceuticals manufactured and sold by AstraZeneca UK Limited and AstraZeneca AB, Sweden.

Headquarters
Cherni Vrah 51 Bl. Biznes Gardan Ofis H Et. 10
Sofia; Sofia - city; Postal Code: 1407

Contact Details: Purchase the Astrazeneca Bulgaria EOOD report to view the information.

Basic Information
Total Employees:
Purchase the Astrazeneca Bulgaria EOOD report to view the information.
Outstanding Shares:
Purchase the Astrazeneca Bulgaria EOOD report to view the information.
Registered Capital:
Purchase the Astrazeneca Bulgaria EOOD report to view the information.
Financial Auditors:
Purchase the Astrazeneca Bulgaria EOOD report to view the information.
Incorporation Date:
November 19, 2010
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astrazeneca Bulgaria EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
17.38%
Total operating revenue
17.28%
Operating profit (EBIT)
34.2%
EBITDA
17.5%
Net Profit (Loss) for the Period
41.58%
Total assets
-42.65%
Total equity
-71.81%
Operating Profit Margin (ROS)
0.85%
Net Profit Margin
0.97%
Return on Equity (ROE)
29.62%
Quick Ratio
-1.76%
Cash Ratio
-1.97%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?